GlassScriptPhysician profile
Michael D Reiner
NPI 1285698381
$1,166.31
in general payments reported to CMS, 2019-2025
18 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $211 · 2021: $77.74 · 2022: $62.25 · 2023: $226 · 2024: $236 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lucid Diagnostics INC. | $305.85 | 2023-2024 | |
| Novo Nordisk INC | $221.15 | 2019-2024 | Rybelsus, Ozempic |
| Amgen INC. | $97.59 | 2019-2024 | Repatha, Otezla |
| Sunovion Pharmaceuticals INC. | $93.19 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $80.59 | 2019-2024 | Farxiga |
| Exact Sciences Corporation | $59.22 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.66 | 2019-2021 | |
| Dexcom, INC. | $55.19 | 2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $32.27 | 2022-2024 | |
| Mallinckrodt Enterprises LLC | $27.96 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.60 | 2023 | |
| Axsome Therapeutics, INC. | $18.64 | 2025 | Auvelity |
| Lilly USA, LLC | $18.39 | 2025 | Mounjaro, Zepbound |
| Genentech USA, INC. | $17.86 | 2020 | |
| Advanced Respiratory, INC | $17.63 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $14.96 | 2021 | |
| Allergan, INC. | $14.88 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Reiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.